Trivium Point Advisory’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-2,893
| Closed | -$267K | – | 335 |
|
|
2024
Q2 | $267K | Buy |
2,893
+388
| +15% | +$35.8K | 0.04% | 264 |
|
|
2024
Q1 | $239K | Sell |
2,505
-803
| -24% | -$76.7K | 0.05% | 198 |
|
|
2023
Q4 | $252K | Sell |
3,308
-21,765
| -87% | -$1.66M | 0.06% | 179 |
|
|
2023
Q3 | $1.75M | Sell |
25,073
-5,007
| -17% | -$348K | 0.48% | 70 |
|
|
2023
Q2 | $2.84M | Sell |
30,080
-718
| -2% | -$67.7K | 0.77% | 39 |
|
|
2023
Q1 | $2.55M | Buy |
30,798
+1,022
| +3% | +$84.6K | 0.69% | 43 |
|
|
2022
Q4 | $2.29M | Sell |
29,776
-297
| -1% | -$22.9K | 0.67% | 46 |
|
|
2022
Q3 | $2.6M | Buy |
30,073
+385
| +1% | +$33.3K | 0.81% | 35 |
|
|
2022
Q2 | $2.92M | Sell |
29,688
-72
| -0.2% | -$7.09K | 0.88% | 30 |
|
|
2022
Q1 | $3.58M | Sell |
29,760
-13,117
| -31% | -$1.58M | 0.8% | 35 |
|
|
2021
Q4 | $5.56M | Buy |
42,877
+70
| +0.2% | +$9.07K | 1.17% | 20 |
|
|
2021
Q3 | $4.75M | Sell |
42,807
-311
| -0.7% | -$34.5K | 1.13% | 19 |
|
|
2021
Q2 | $4.47M | Buy |
43,118
+3,094
| +8% | +$320K | 1.11% | 18 |
|
|
2021
Q1 | $3.35M | Buy |
40,024
+4,319
| +12% | +$361K | 0.91% | 19 |
|
|
2020
Q4 | $3.19M | Buy |
35,705
+1,665
| +5% | +$149K | 0.92% | 18 |
|
|
2020
Q3 | $2.72M | Buy |
34,040
+8,411
| +33% | +$671K | 0.96% | 21 |
|
|
2020
Q2 | $1.78M | Buy |
25,629
+2,547
| +11% | +$177K | 0.71% | 48 |
|
|
2020
Q1 | $1.59M | Sell |
23,082
-1,890
| -8% | -$130K | 0.82% | 46 |
|
|
2019
Q4 | $1.94M | Sell |
24,972
-1,845
| -7% | -$143K | 0.75% | 45 |
|
|
2019
Q3 | $2.01M | Sell |
26,817
-1,401
| -5% | -$105K | 0.92% | 38 |
|
|
2019
Q2 | $1.74M | Buy |
28,218
+936
| +3% | +$57.7K | 0.77% | 49 |
|
|
2019
Q1 | $1.74M | Buy |
27,282
+480
| +2% | +$30.6K | 0.81% | 43 |
|
|
2018
Q4 | $1.37M | Buy |
+26,802
| New | +$1.37M | 0.83% | 53 |
|